Bioengineered Chewing Gum Targets Cancer-Linked Oral Microbes for Better Oral Health

Research from Penn Dental Medicine has shown that a bioengineered chewing gum can reduce levels of three harmful microbes linked to worse outcomes in oral cancer. The gum, developed by a team led by Henry Daniell, combines a bean-derived protein with an antimicrobial peptide called protegrin to target bacteria associated with oral squamous cell carcinoma.

The study focused on Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella intermedia—bacteria previously identified as contributing to tumor progression and poor prognosis in head and neck cancers. When the chewing gum was formulated to include both the plant-based protein and protegrin, it significantly reduced the presence of these microbes in laboratory tests.

How the Gum Works

The bioengineered gum uses a dual-action approach. First, a protein derived from lablab beans acts as a decoy, binding to the harmful bacteria and preventing them from attaching to oral tissues. Second, protegrin, an antimicrobial peptide, directly kills the targeted microbes. This combination allows the gum to reduce pathogenic bacteria while leaving beneficial oral microbiota largely unaffected.

Potential for Affordable Prevention

Researchers emphasize that the gum is designed to be low-cost and easy to use, making it a promising tool for oral cancer prevention, particularly in low-resource settings. Unlike traditional treatments, it does not require medical supervision and could be used as a daily hygiene product to lower microbial risk factors associated with cancer development.

Next Steps in Research

• The current findings are based on laboratory studies. clinical trials in humans are needed to confirm effectiveness in real-world use.
• Future research will focus on optimizing the gum’s formulation and testing its impact over longer periods.
• Scientists also aim to study whether reducing these specific microbes leads to measurable decreases in lesion formation or cancer incidence.

While the results are preliminary, the approach represents a novel strategy in oral cancer prevention by targeting the microbiome. If proven effective in human studies, such a gum could become a simple, accessible complement to existing screening and prevention methods for head and neck squamous cell carcinoma.